GSK and J&J back $1 bln biotech spin-off from Index Ventures

LONDON, Feb 2 (Reuters) - Index Ventures, an early investor in technology hits like Skype and Dropbox, is spinning off its biotech portfolio into a new $1 billion business, with backing from drug giants GlaxoSmithKline and Johnson & Johnson .